Joseph O'Donoghue, PhD

Memorial Sloan-Kettering Cancer CenterNew York, New York - 10065 (646-888-0023) |
- CLINICAL TRIALS 1
- CONDITIONS4
- INTERVENTIONS1
- SINCE2005

Treatment of Patients With Advanced Renal Cancer With a Radio-Labeled Antibody Yttrium-90 Conjugated Chimeric G250
July 2005 - December 2009
Neoplasms
Carcinoma, Renal Cell
Kidney Neoplasms
Carcinoma
Yttrium-90 Conjugated Chimeric G250 (90y-Cg250)



